Business

Ladder Capital Corp. (LADR) reports Q4 net income of $31.4 million, beating analysts' estimates. Adjusted earnings were 27 cents per share, revenue was $119.5 million.

Published on: February 06, 2025, 02:05 PM UTC

Zimmer Biomet forecasts below-estimate profit due to currency headwinds, despite strong Q4 results.

Published on: February 06, 2025, 02:04 PM UTC

Compare taxes: Sweden's pre-filled returns vs. the US's complex, 13-hour process. See why the US tax code is so complicated and how it could be simplified.

Published on: February 06, 2025, 02:03 PM UTC

Ford reported a fourth-quarter earnings and revenue beat, but issued muted full-year guidance. The guidance presumes headwinds related to market factors, such as pricing, but does not include changes in policy like the potential loss of EV tax credits or tariffs. Ford said it sees full-year 2025 adjusted EBIT of $7.0 billion to $8.5 billion, and $3.5 billion to $4.5 billion in adjusted free cash flow.

Published on: February 06, 2025, 02:03 PM UTC

Elon Musk and OpenAI CEO Sam Altman's legal battle over the future of artificial intelligence heats up, with a jury trial potentially years away. Musk accuses OpenAI of prioritizing profits over its nonprofit mission, while OpenAI denies wrongdoing. The case involves Microsoft, LinkedIn founder Reed Hoffman, and Tesla.

Published on: February 06, 2025, 02:03 PM UTC

Vanguard significantly reduced expense ratios across its mutual funds and ETFs, lowering its average asset-weighted expense ratio to 0.07%. This move benefits investors by boosting long-term returns and highlights Vanguard's commitment to minimizing costs and maximizing value for its clients.

Published on: February 06, 2025, 02:02 PM UTC

Ford CEO warns Trump's tariffs could devastate auto industry, warns of higher prices and job losses.

Published on: February 06, 2025, 02:02 PM UTC

Honeywell is splitting into three independent, industry-leading companies: Honeywell Automation, Honeywell Aerospace and Advanced Materials. The separation is expected to happen in the second half of 2026. Honeywell shares fell almost 3% in pre-market trading as investors digested the news.

Published on: February 06, 2025, 02:02 PM UTC

Eli Lilly Q4 beats: GLP-1 sales rise 45%, stock up 2%. Mounjaro sales hit $11.5B, but miss estimates. Full-year revenue up 32% to $45B. Lilly remains growth leader in GLP-1s, with potential $200B market opportunity. Company's focus on new indications and pill option drives long-term growth prospects.

Published on: February 06, 2025, 02:01 PM UTC

Eli Lilly reports strong Q4 earnings, with 45% revenue growth driven by GLP-1 drugs. Despite missing estimates on Mounjaro sales, the company remains a growth leader in the pharma industry, pursuing clinical trials and developing a pill option.

Published on: February 06, 2025, 02:01 PM UTC